
这个市场不适合进入,已经明显过热并接近价格战区。 新品牌只有12个,但新品牌新上架产品成功率只有24.32%,全部新产品成功率也只有22.22%,而失败新品占77.78%;最近几个月仍在持续出现大量失败新品,说明不是变容易,而是在加速内卷。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这个市场不值得进入,原因不是预算不够,而是已经明显陷入价格战。 用户预算500,000 CNY足以覆盖部分新款入场的前期投入,但市场里新品牌已出现“高投入、低回报”的典型信号,且多数新品利润率只有7.35%~24.86%,其中低于10%的产品已经处在高风险价格战区。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不建议进入:新品牌进入已经明显过热,且新上架产品的赚钱能力很差。 目前样本里可识别的可盈利产品占50.66%,但新发布产品只有21.88%能赚钱;更关键的是,至少看到 Bloom Nutrition、VIRENTIS、Kyhv Nutrition 这些新品牌在同一子类里密集试错,Kyhv Nutrition 3个产品全部亏损,Bloom Nutrition 3个可判断产品全部亏损,说明这里不是“有机会”,而是“强竞争+低容错”。
大品牌还能打,但小品牌不适合硬闯;如果没有明显功能创新或品牌势能,进去就是被价格和流量压死。 证据很直接:老品牌 Venture Pal 的成功款 B0DN6QV16L 定价 $16.99,月销 10,450,月收入 $17,754,550,利润率 24.62%;B0DN6T1QGD 月销 20,000,月收入 $19,980,000,利润率 12.0%。它的共性不是低价,而是高钠、细分人群、老 ASIN 复用。相反,真正像“小品牌”的成功例子只有 VIRENTIS:B0FN3XHC6G 售价 $11.19,利润率 21.14%,月销 2,000,月收入 $2,238,000;B0FN4DT7VY 售价 $14.54,利润率 22.6%,月销 800;B0FN4KZNPN 售价 $13.90,利润率 24.25%,月销 700。它们能活下来,是因为做了“8种电解质+6种维生素、低钠/无糖、便携 stick pack”的明确差异化,不是普通电解质粉。反例更重要:Bloom 的 B0GYQG1Q7W、B0GYQJCK7R 都只有 7.35%~7.4% 利润率,B0H136LZMK 甚至还没跑出有效销量;Kyhv Nutrition 的 B0FKB65RV9 利润率 19.38% 但已失败,说明在这个市场里“看起来有利润”并不等于能卖得动,价格战和同质化会直接吞掉新入场者。
结论很硬:不推荐小商家进入;大品牌也只有在能投入更高预算、做出更强功能区隔时才可能进入。 你的预算 500,000 CNY 足以覆盖单个 ASIN 的前期铺货和推广,但在这个类目里,成功样本更像是“高投入+强品牌+细分功能”而不是普通新品;如果没有做到高钠/低钠、无糖、便携、特定人群定位这类可感知差异,就会落入低于 10% 利润率的价格战区。
这个市场不值得进,属于明显的高竞争低风险收益市场,且新品牌失败率非常高。 新品利润主要卡在20%~30%,但真正适合新品牌复制的成功样本很少;反过来,低利润和失败样本集中,说明这里不是“赚快钱”的市场,而是老品牌和强营销品牌在吃大头。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0D4R7H3T3 | NatureWorks | 2024-05-21 | Yes | $23.04 | 9000pcs | $207360.0 | 27.98% | $58019.33 |
![]() | B0DN6QTZNG | Venture Pal | 2025-03-24 | Yes | $16.99 | 10450pcs | $177545.5 | 24.86% | $44137.82 |
![]() | B0DN6QV16L | Venture Pal | 2025-03-24 | Yes | $16.99 | 10450pcs | $177545.5 | 24.62% | $43711.71 |
![]() | B0DN6T1QGD | Venture Pal | 2025-02-27 | Yes | $9.99 | 20000pcs | $199800.0 | 12.0% | $23976.0 |
![]() | B0C6FLJB3F | Cure Hydration | 2023-05-26 | Yes | $15.99 | 6000pcs | $95940.0 | 24.69% | $23687.59 |
![]() | B0CLS7YKKX | Venture Pal | 2023-10-25 | Yes | $15.05 | 6000pcs | $90300.0 | 22.24% | $20082.72 |
![]() | B0GGHB56SM | Dralot Nutrition | 2026-01-13 | Yes | $18.17 | 4000pcs | $72680.0 | 26.71% | $19412.83 |
![]() | B0D2HB8GBB | Venture Pal | 2024-07-05 | Yes | $16.45 | 4500pcs | $74025.0 | 24.46% | $18106.52 |
![]() | B0D2GNC5X4 | Venture Pal | 2024-07-05 | Yes | $16.47 | 4500pcs | $74115.0 | 24.31% | $18017.36 |
![]() | B0DN6WQDJP | Venture Pal | 2024-11-15 | Yes | $16.48 | 4500pcs | $74160.0 | 24.09% | $17865.15 |
![]() | B0CJCR8XZF | BODYARMOR | 2023-10-18 | Yes | $15.07 | 5000pcs | $75350.0 | 22.64% | $17059.24 |
![]() | B09YKLGG7X | Boobie Brands | 2022-04-21 | Yes | $22.43 | 2000pcs | $44860.0 | 29.55% | $13256.13 |
![]() | B09LFZ57Z1 | REDMOND | 2021-11-09 | Yes | $12.59 | 4000pcs | $50360.0 | 25.11% | $12645.4 |
![]() | B0D9B7PTJZ | Venture Pal | 2024-12-12 | Yes | $16.34 | 3000pcs | $49020.0 | 25.01% | $12259.91 |
![]() | B0CLSC8ZFJ | Venture Pal | 2023-10-25 | Yes | $15.03 | 3000pcs | $45090.0 | 26.88% | $12120.2 |
![]() | B0CX93D2XY | Venture Pal | 2024-03-06 | Yes | $15.1 | 3000pcs | $45300.0 | 22.3% | $10101.9 |
![]() | B0CLSB6F4P | Venture Pal | 2023-10-25 | Yes | $14.99 | 3000pcs | $44970.0 | 22.26% | $10010.33 |
![]() | B0D2GRYC4R | Venture Pal | 2024-07-05 | Yes | $9.77 | 9000pcs | $87930.0 | 10.45% | $9188.69 |
![]() | B0DMWWB8MB | Cure Hydration | 2024-11-13 | Yes | $15.99 | 2000pcs | $31980.0 | 24.42% | $7809.52 |
![]() | B0DS2WWZZ4 | CELSIUS | 2025-01-02 | Yes | $12.65 | 3000pcs | $37950.0 | 19.74% | $7491.33 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0GGHB56SM | Dralot Nutrition | 2026-01-13 | Yes | $18.17 | 4000pcs | $72680.0 | 26.71% | $19412.83 |
![]() | B0FN3XHC6G | VIRENTIS | 2025-12-13 | Yes | $11.19 | 2000pcs | $22380.0 | 21.14% | $4731.14 |
![]() | B0FKN6RCLB | Venture Pal | 2026-01-26 | Yes | $16.83 | 800pcs | $13464.0 | 24.54% | $3304.07 |
![]() | B0FN4DT7VY | VIRENTIS | 2025-08-20 | Yes | $14.54 | 800pcs | $11632.0 | 22.6% | $2628.84 |
![]() | B0FKN3CHKP | Venture Pal | 2026-01-26 | Yes | $16.98 | 600pcs | $10188.0 | 24.78% | $2524.59 |
![]() | B0FN4KZNPN | VIRENTIS | 2025-08-20 | Yes | $13.9 | 700pcs | $9730.0 | 24.25% | $2359.53 |
![]() | B0FL17SMWY | Saltivate | 2025-08-06 | Yes | $21.99 | 300pcs | $6597.0 | 32.9% | $2170.42 |
![]() | B0FKN5CN6W | Venture Pal | 2026-01-26 | Yes | $16.8 | 500pcs | $8400.0 | 24.47% | $2055.48 |
![]() | B0FKN5Q812 | Venture Pal | 2026-01-26 | Yes | $16.84 | 300pcs | $5052.0 | 24.56% | $1240.78 |
![]() | B0FNDHN9Y1 | ZestLytes | 2025-08-22 | Yes | $11.67 | 450pcs | $5251.5 | 13.67% | $717.89 |
![]() | B0FKN3ZTBJ | Venture Pal | 2025-07-31 | Yes | $9.89 | 550pcs | $5439.5 | 11.18% | $608.14 |
![]() | B0FSQ8R3S9 | Saltivate | 2026-02-10 | Yes | $9.99 | 300pcs | $2997.0 | 18.94% | $567.64 |
![]() | B0FMF5JF4L | Syloni | 2025-08-22 | Yes | $12.87 | 400pcs | $5148.0 | 10.33% | $531.79 |
![]() | B0FN4B7YD9 | VIRENTIS | 2025-08-20 | Yes | $13.63 | 100pcs | $1363.0 | 23.03% | $313.9 |
这个市场不值得进入,已经接近价格战区,且新品牌成功率偏低。总体上看,新产品只有21.88%能跑成,市场里77.78%的新产品没跑通;按品牌看,新品牌新上架成功率只有25.00%,失败率75.00%,这说明多数新品牌一进来就被打回去,不是一个适合轻量试水的市场。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场不值得进入:2025-2026 的新品牌扩张很快,但成功率明显偏低,已经进入高竞争/接近价格战状态。 近两年新品牌里,真正成功的新增产品只有 14 个,失败的有 49 个,新品成功率只有 22.22%;而仅 2026 年就出现大量失败新品,说明最近进入难度在上升,不是变容易。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 1 | 8 | 3 | 4 | 1 | 0 | 15 |
| 2026 | 0 | 2 | 2 | 1 | 5 | 0 | 0 | 22 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 |
| 2025/8 | 0 | 0 | 8 | 2 | 3 | 1 | 0 | 4 |
| 2025/9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/12 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 2 |
| 2026/1 | 0 | 1 | 0 | 0 | 5 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/4 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 3 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |